pubmed-article:9074529 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9074529 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:9074529 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:9074529 | lifeskim:mentions | umls-concept:C0034603 | lld:lifeskim |
pubmed-article:9074529 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
pubmed-article:9074529 | lifeskim:mentions | umls-concept:C0085101 | lld:lifeskim |
pubmed-article:9074529 | lifeskim:mentions | umls-concept:C0439828 | lld:lifeskim |
pubmed-article:9074529 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:9074529 | pubmed:dateCreated | 1997-4-9 | lld:pubmed |
pubmed-article:9074529 | pubmed:abstractText | In this study, we examined the factors that may influence tumor dosimetry in the radioimmunotherapy of solid, CEA-expressing cancers. | lld:pubmed |
pubmed-article:9074529 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:language | eng | lld:pubmed |
pubmed-article:9074529 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9074529 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9074529 | pubmed:month | Mar | lld:pubmed |
pubmed-article:9074529 | pubmed:issn | 0161-5505 | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:GoldenbergD... | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:SharkeyR MRM | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:SiegelJ AJA | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:ZhangC HCH | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:YingZZ | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:DunnR MRM | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:BehrT MTM | lld:pubmed |
pubmed-article:9074529 | pubmed:author | pubmed-author:JuweidM EME | lld:pubmed |
pubmed-article:9074529 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9074529 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:9074529 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9074529 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9074529 | pubmed:pagination | 409-18 | lld:pubmed |
pubmed-article:9074529 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:meshHeading | pubmed-meshheading:9074529-... | lld:pubmed |
pubmed-article:9074529 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9074529 | pubmed:articleTitle | Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. | lld:pubmed |
pubmed-article:9074529 | pubmed:affiliation | Garden State Cancer Center, Center for Molecular Medicine and Immunology, Newark, New Jersey, USA. | lld:pubmed |
pubmed-article:9074529 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9074529 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9074529 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9074529 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9074529 | lld:pubmed |